相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non-Small-Cell Lung Cancer
Edward B. Garon et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non-Small Cell Lung Cancer Growth
Edward B. Garon et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Mitochondrial activation by inhibition of PDKII suppresses HIF1α signaling and angiogenesis in cancer
G. Sutendra et al.
ONCOGENE (2013)
Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo
Benedikt Feuerecker et al.
CANCER BIOLOGY & THERAPY (2012)
Expression of a Truncated Active Form of VDAC1 in Lung Cancer Associates with Hypoxic Cell Survival and Correlates with Progression to Chemotherapy Resistance
M. Christiane Brahimi-Horn et al.
CANCER RESEARCH (2012)
Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants
Jerome Kluza et al.
CANCER RESEARCH (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis
Yumin Hu et al.
CELL RESEARCH (2012)
Comparison of Spheroids Formed by Rat Glioma Stem Cells and Neural Stem Cells Reveals Differences in Glucose Metabolism and Promising Therapeutic Applications
Marie Morfouace et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
Martin J. Edelman et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
Xue Xue et al.
MOLECULAR PHARMACEUTICS (2012)
Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Kasirajan Ayyanathan et al.
PLOS ONE (2012)
In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines
Wolfgang Fiebiger et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Sensitivity to Low-Dose/Low-LET Ionizing Radiation in Mammalian Cells Harboring Mutations in Succinate Dehydrogenase Subunit C is Governed by Mitochondria-Derived Reactive Oxygen Species
Nukhet Aykin-Burns et al.
RADIATION RESEARCH (2011)
Dichloroacetate Induces Apoptosis of Epithelial Ovarian Cancer Cells Through a Mechanism Involving Modulation of Oxidative Stress
Ghassan M. Saed et al.
REPRODUCTIVE SCIENCES (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
The cellular response to hypoxia: tuning the system with microRNAs
Joseph Loscalzo
JOURNAL OF CLINICAL INVESTIGATION (2010)
Metabolic Modulation of Glioblastoma with Dichloroacetate
E. D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The Warburg Effect Suppresses Oxidative Stress Induced Apoptosis in a Yeast Model for Cancer
Christoph Ruckenstuhl et al.
PLOS ONE (2009)
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Human kinetics of orally and intravenously administered low-dose 1,2-13C-dichloro acetate
Minghong Jia et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children
PW Stacpoole et al.
PEDIATRICS (2006)
The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation
M Buzzai et al.
ONCOGENE (2005)
Drug therapy: Multidisciplinary management of lung cancer
A Spira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Activation of K+ channels: an essential pathway in programmed cell death
CV Remillard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
分享论文
